SEC Info - Commonwealth Income & Growth Fund V - ‘10-Q’ for 9/30/19

SEC Info℠

Home

Help

Please Sign In

Commonwealth Income & Growth Fund V – ‘10-Q’ for 9/30/19 – ‘EX-31.1’

On: Wednesday, 11/13/19, at 2:36pm ET · For: 9/30/19 · Accession #: 1654954-19-12828 · File #: 333-108057

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/13/19  Commonwealth Income & Growth Fd V 10-Q        9/30/19   46:1.6M                                   Blueprint/FA

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    223K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
25: R1          Document and Entity Information                     HTML     44K 
41: R2          Condensed Balance Sheets                            HTML     85K 
35: R3          Condensed Balance Sheets (Parenthetical)            HTML     20K 
15: R4          Condensed Statements of Operations                  HTML     59K 
27: R5          Condensed Statement of Partners' Capital            HTML     32K 
43: R6          Condensed Statements of Cash Flow                   HTML     36K 
37: R7          Business                                            HTML     24K 
13: R8          Summary of Significant Accounting Policies          HTML     32K 
29: R9          Information Technology, Medical Technology,         HTML     37K 
                Telecommunications Technology, Inventory                         
                Management Equipment (''Equipment'')                             
36: R10         Related Party Transactions                          HTML     24K 
42: R11         Notes Payable                                       HTML     32K 
28: R12         Supplemental Cash Flow Information                  HTML     20K 
16: R13         Commitments and Contingencies                       HTML     23K 
34: R14         Summary of Significant Accounting Policies          HTML     40K 
                (Policies)                                                       
40: R15         Summary of Significant Accounting Policies          HTML     18K 
                (Tables)                                                         
26: R16         Information Technology, Medical Technology,         HTML     31K 
                Telecommunications Technology, Inventory                         
                Management Equipment (Tables)                                    
14: R17         Related Party Transactions (Tables)                 HTML     23K 
38: R18         Notes Payable (Tables)                              HTML     32K 
39: R19         Supplemental Cash Flow Information (Tables)         HTML     19K 
23: R20         Business (Details)                                  HTML     17K 
18: R21         Summary of Significant Accounting Policies          HTML     21K 
                (Details)                                                        
31: R22         Information Technology, Medical Technology,         HTML     25K 
                Telecommunications Technology, Inventory                         
                Management Equipment (Details)                                   
46: R23         Information Technology, Medical Technology,         HTML     23K 
                Telecommunications Technology, Inventory                         
                Management Equipment (Details 1)                                 
22: R24         Information Technology, Medical Technology,         HTML     25K 
                Telecommunications Technology, Inventory                         
                Management Equipment (Details 2)                                 
17: R25         Information Technology, Medical Technology,         HTML     23K 
                Telecommunications Technology, Inventory                         
                Management Equipment (Details 3)                                 
30: R26         Information Technology, Medical Technology,         HTML     23K 
                Telecommunications Technology, Inventory                         
                Management Equipment (Details Narrative)                         
45: R27         Related Party Transactions (Details)                HTML     19K 
21: R28         Notes Payable (Details)                             HTML     55K 
20: R29         Notes Payable (Details 1)                           HTML     28K 
12: R30         Notes Payable (Details Narrative)                   HTML     17K 
24: R31         Supplemental Cash Flow Information (Details)        HTML     18K 
44: R32         Supplemental Cash Flow Information (Details 1)      HTML     18K 
33: XML         IDEA XML File -- Filing Summary                      XML     78K 
32: EXCEL       IDEA Workbook of Financial Reports                  XLSX     36K 
 6: EX-101.INS  XBRL Instance -- cigf5-20190930                      XML    400K 
 8: EX-101.CAL  XBRL Calculations -- cigf5-20190930_cal              XML     79K 
 9: EX-101.DEF  XBRL Definitions -- cigf5-20190930_def               XML     76K 
10: EX-101.LAB  XBRL Labels -- cigf5-20190930_lab                    XML    314K 
11: EX-101.PRE  XBRL Presentations -- cigf5-20190930_pre             XML    221K 
 7: EX-101.SCH  XBRL Schema -- cigf5-20190930                        XSD     90K 
19: ZIP         XBRL Zipped Folder -- 0001654954-19-012828-xbrl      Zip     45K

‘EX-31.1’ — Certification — §302 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

C: C:

Blueprint

31.1 THE RULE 15d-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Kimberly A. Springsteen-Abbott certify that:

I have reviewed this quarterly report on Form 10-Q of Commonwealth Income & Growth Fund V (the Registrant);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Kimberly A. Springsteen-Abbott

Kimberly A. Springsteen-Abbott

Chief Executive Officer

November 13, 2019

Dates Referenced Herein

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	11/13/19	None on these Dates
For Period end:	9/30/19
		List all Filings

↑Top

Filing Submission 0001654954-19-012828 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)